Cite

    Herrmann, I. et al. (2020). Shortened immunotherapy dose‐escalation saves time, but is it safe? A case‐control study comparing the rates of adverse reactions between conventional and fast‐escalation subcutaneous immunotherapy protocols during the induction phase. Veterinary dermatology. 31 (6), pp. 454-e120. [Online].